Skip to main content
SpringerLink
Log in

Kolorektales Karzinom

  • Chapter
Therapiekonzepte Onkologie

Zusammenfassung

Die meisten kolorektalen Karzinome entstehen aus adenomatösen Polypen. Mehr als 90% sind Adenokarzinome, manchmal mit reichlich extrazellulärem oder intrazellulärem (Siegelringzellen) Schleim. Auch Karzinoide, Leiomyosarkome und Non-Hodgkin-Lymphome kommen vor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Parkin DM, Whelan S (eds) (1990) Patterns of cancer in five continents. IARC Scientific Publications No 102, Lyon

    Google Scholar 

  2. Trock B, Lanza E, Greenwald P (1990) Dietary fiber, vegetables and colon cancer: critical review and meta-analysis of the epidemiologic evidence. JNCI 82: 650–661

    Google Scholar 

  3. Bufill J (1990) Colorectal Cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Int Med 113: 779–788

    Article  PubMed  CAS  Google Scholar 

  4. Lynch HT (1990) The surgeon and colorectal cancer genetics. Arch Surg 125: 698–701

    Article  PubMed  CAS  Google Scholar 

  5. Hermanek P (1982) Evolution und pathology of rectal cancer. World J Surg 6: 502–509

    Article  PubMed  CAS  Google Scholar 

  6. Blenkinsopp WK, Stewart-Brown S, Blesovsky L et al. (1981) Histopathology reporting in large bowel cancer. J Clin Pathol 34: 509–513

    Article  PubMed  CAS  Google Scholar 

  7. Qizilbash AH (1982) Pathologic studies in colorectal cancer; a guide to the surgical pathology examination of colorectal specimens and review of features of prognostic significance. Pathol Annu 17: 1–46

    PubMed  Google Scholar 

  8. Dukes CE (1932) The classification of cancer of the rectum. J Pathol 35: 323–332

    Article  Google Scholar 

  9. Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846–851

    Article  PubMed  CAS  Google Scholar 

  10. Hermanek P, Sobin LH (eds) (1987) TNM classification of malignant tumors. (International Union against cancer), 4th ed. Springer, Berlin

    Google Scholar 

  11. Nathanson SD, Schultz L, Tilley B et al. (1986) Carcinoma of the colon and rectum: A comparison of staging classifications. Ann Surg 52: 428–433

    Google Scholar 

  12. Cohen AM, Shank B, Friedman MA (1989). In: De Vita V, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology. Lippincott, 3e ed, pp 895–964

    Google Scholar 

  13. Willett CG, Tepper JE, Cohen AM et al. (1984) Failure patterns following curative resection of colonic carcinoma. Ann Surg 200: 685–690

    Article  PubMed  CAS  Google Scholar 

  14. Rich T, Gunderson LL, Lew R et al. (1983) Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 52: 1317–1329

    Article  PubMed  CAS  Google Scholar 

  15. Higgins GA, Humphrey EW, Dwight 1W et al. (1986) Preoperative radiation and surgery for cancer of the rectum: Veterans Administration Surgical Oncology Group Trial 11. Cancer 58: 352–359

    Google Scholar 

  16. Dahl O, Horn A, Morild I et al. (1990) Low-dose preoprative radiation postpones recurences in operable rectal cancer. Cancer 66: 228602294

    Google Scholar 

  17. Stockholm Rectal Cancer Study Group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66: 49–55

    Article  Google Scholar 

  18. Gerard A, Buyse M, Norlinger B et al. (1988) Pre-operative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 208: 606–614

    Google Scholar 

  19. Balsev I, Pedersen M, Teglbjaerg PS et al. (1986) Post-operative radiotherapy in Duke’s B and C carcinoma of the rectum and rectosigmoid: Cancer 58: 22–28

    Google Scholar 

  20. Fisher B, Wolmark N, Rockette H et al. (1986) Postoperative adjuvant chemotherapy or radiotherapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80: 21–29.

    Article  Google Scholar 

  21. Treumiet-Donker AD, Van Putten LJ, Wereldsma JC et al. (1991) Postoperative radiation therapy for rectal cancer. 67: 2042–2048

    Google Scholar 

  22. Pahlman L, Glimelius B (1990) Pre-or post-operative radiotherapy in rectal and recto-sigmoid carcinoma. Ann Surg 211: 187–195

    Article  PubMed  CAS  Google Scholar 

  23. Blijham GH (1991) Chemotherapy of colorectal cancer. Anti-Cancer Drugs 2: 233–245

    Article  PubMed  CAS  Google Scholar 

  24. Hansen RM (1990) Systemic therapy in metastatic colorectal cancer. Arch Intern Med 150: 2265–2269

    Article  PubMed  CAS  Google Scholar 

  25. Glimelius B (1992) For the Nordic Gastrointestinal Tumor Adjuvant Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904–911

    Google Scholar 

  26. Pinedo HM, Peters GJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653–1664

    PubMed  CAS  Google Scholar 

  27. Petrelli N, Herrera L, Rustum Y et al. (1987) A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5: 1559–1565

    PubMed  CAS  Google Scholar 

  28. Ehrlichmann C, Fine S, Wong A et al. (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6: 469–475

    Google Scholar 

  29. Poon MA, O’Connell MJ, Moertel CG et al. (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407–1418

    PubMed  CAS  Google Scholar 

  30. Petrelli N, Douglass HO, Herrera L et al. (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase Ill trial. J Clin Oncol 7: 1419–1426

    PubMed  CAS  Google Scholar 

  31. Valone FH, Friedman MA, Wittlinger PS et al. (1989) Treatment of patients with advanced, colorectal carcinoma with fluorouracil alone, high-dose leucovorin plus fluorouracil or sequential methotrexate, fluorouracil and leucovorin; a randomized trial of the Northern California Oncology Group. J Clin Oncol 7: 1427–1436

    PubMed  CAS  Google Scholar 

  32. Doroshow JH, Mutlhauf P, Leong L et al. (1990) Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 8: 491–501

    PubMed  CAS  Google Scholar 

  33. Labianca R, Pancera G, Aitini E et al. (1991) Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase Ill study of GISCAD. Ann Oncol 2: 673–679

    Google Scholar 

  34. Glimelius B (1989) For the Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial. J Clin Oncol 7: 1437–1446

    Google Scholar 

  35. Herrmann R, Knuth A, Kleeberg U et al. (1986) Randomized trial of sequential methotrexate and 5-fluorouracil (5-FU) vs 5-FU alone in metastatic colorectal carcinoma. Proc Am Soc Clin Oncol 5: 91 (abstr 355)

    Google Scholar 

  36. Miachiavelli M, Leone BA, Romerto A et al. (1990) Advanced colorectal carcinoma: a prospective randomized trial of sequential methotrexate (MTX)-5-fluorouracil (5-FU) vs 5FU alone. Proc Am Soc Clin Oncol 9: 102 (abstr 394)

    Google Scholar 

  37. Blijham GH, Selleslag J, Sahmout T et al. (1993) The modulation of high-dose 5-Fluorouracil (HD-FU) with low-dose methotrexate (LD-MTX) in metastatic colorectal cancer: a phase Ill study of the EORTC GI Cancer Cooperative Group. Proc ASCO

    Google Scholar 

  38. Buyse M (1992) For the Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896–903

    Google Scholar 

  39. Lokich JJ, Ahlgren JD, Gullo JJ et al. (1989) A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-Atlantic oncology program study. J Clin Oncol 7: 425–432

    PubMed  CAS  Google Scholar 

  40. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC (1988) Adjuvant therapy of colorectal cancer. J Am Med Assoc 259: 3571–3578

    Article  CAS  Google Scholar 

  41. Moertel CG, Fleming TR, Macdonald JS et al. (1990) Levamisole and fluorouracil for surgical adjuvant therapy of colon carcinoma. N Engl J Med 322: 352–358

    Article  PubMed  CAS  Google Scholar 

  42. Krook JE, Moertel CG, Gunderson LL et al. (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709–715

    Article  PubMed  CAS  Google Scholar 

  43. Weaver D, Lindblad AS (1990) Radiation therapy and 5-fluorouracil (5-FU) with or without MeCCNU for the treatment of patients with surgically adjuvant adenocarcinoma of the rectum. Proc ASCO 9: 106 (abstr 409)

    Google Scholar 

  44. Kemeny NE (1992) Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! In: DeVita V, Hellman S, Rosenberg SA (eds) Important Advances in Oncology. Lippincott, Philadelphia, pp 207–227

    Google Scholar 

  45. O’Connell MJ (1992) Is hepatic infusion of chemotherapy effective treatment for liver metastases? No! In: DeVita V, Hellman S, Rosenberg SA (eds) Important Advances in Oncology. Lippincott, Philadelphia, pp 228–234

    Google Scholar 

  46. O’Connell MJ (1990) Is portal-vein fluorouracil hepatic infusion effective colon cancer surgical adjuvant therapy? J Cli Oncol 8: 1454–1456

    Google Scholar 

Download references

Authors
  1. G. H. Blijham
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Blijham, G.H. (1993). Kolorektales Karzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation